Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.
Journal Information
Full Title: Acta Haematol
Abbreviation: Acta Haematol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of Interest Statement P.L. receives research grants from Janssen-Cilag and consulting honoraria from Janssen-Cilag, Abbvie, and Roche. B.E. has received personal fee from Janssen-Cilag, Roche, Novartis, Abbvie, Gilead, Celgene, ArQule, Astrazeneca, Oxford Biomedica, and Adaptive Biotechnologies and research funding from Janssen-Cilag, Roche, Abbvie, Gilead, and Beigene."
Funding Disclosure
Evidence found in paper:
"Funding Sources The authors did not receive any funding."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025